Hoerter Steven L. (CIK 0001533451)

Latest company ownership

Shares held
8,000
Last filed at
Nov 25, 2025
Confidence Score
85.6
2025Q4
Confidence Score History
2025Q4 2025Q4
Role: Chief Commercial Officer
Shares held
5,000
Last filed at
Mar 5, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 17, 2025 Oct 20, 2025 MBX Biosciences, Inc. Director Buy 97.5 +20,000 100.00% $265K
Mar 1, 2019 Mar 5, 2019 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 20.0 -10,000 -31.37% $670.1K
Feb 16, 2019 Feb 20, 2019 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 22.5 -1,040 -8.68% $60.4K
Jan 20, 2019 Jan 23, 2019 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 20.0 -5,769 -38.46% $304.7K
Aug 24, 2018 Aug 28, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $153.6K
Jul 25, 2018 Jul 27, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $173.4K
Jun 22, 2018 Jun 26, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $200K
May 23, 2018 May 29, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $175.8K
Apr 23, 2018 Apr 25, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $176.2K
Mar 22, 2018 Mar 26, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $173.5K
Feb 22, 2018 Feb 26, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 10.0 -2,050 -100.00% $161.2K
Jan 23, 2018 Jan 25, 2018 AGIOS PHARMACEUTICALS, INC. Chief Commercial Officer Sell 5.0 -25,000 -100.00% $1.9M